nodes	percent_of_prediction	percent_of_DWPC	metapath
Miconazole—NOS2—psoriasis	0.373	1	CbGaD
Miconazole—NOS2—Dexamethasone—psoriasis	0.0688	0.158	CbGbCtD
Miconazole—CYP11B1—Hydrocortisone—psoriasis	0.0549	0.126	CbGbCtD
Miconazole—CYP17A1—Dexamethasone—psoriasis	0.0342	0.0785	CbGbCtD
Miconazole—CYP2A6—Methoxsalen—psoriasis	0.0294	0.0676	CbGbCtD
Miconazole—CYP19A1—Betamethasone—psoriasis	0.0229	0.0526	CbGbCtD
Miconazole—CYP1A2—Clobetasol propionate—psoriasis	0.0214	0.0491	CbGbCtD
Miconazole—CYP2A6—Prednisolone—psoriasis	0.0143	0.0329	CbGbCtD
Miconazole—CYP19A1—Dexamethasone—psoriasis	0.0133	0.0306	CbGbCtD
Miconazole—CYP2B6—Cholecalciferol—psoriasis	0.0127	0.0292	CbGbCtD
Miconazole—CYP1A2—Methoxsalen—psoriasis	0.0112	0.0258	CbGbCtD
Miconazole—CYP2D6—Hydroxyurea—psoriasis	0.0101	0.0232	CbGbCtD
Miconazole—CYP2A6—Dexamethasone—psoriasis	0.00843	0.0194	CbGbCtD
Miconazole—CYP2C19—Cholecalciferol—psoriasis	0.00806	0.0185	CbGbCtD
Miconazole—CYP3A4—Calcitriol—psoriasis	0.00756	0.0174	CbGbCtD
Miconazole—CYP2C9—Cholecalciferol—psoriasis	0.0067	0.0154	CbGbCtD
Miconazole—CYP2D6—Cholecalciferol—psoriasis	0.00613	0.0141	CbGbCtD
Miconazole—CYP3A4—Methoxsalen—psoriasis	0.00588	0.0135	CbGbCtD
Miconazole—ABCB1—Mycophenolate mofetil—psoriasis	0.00564	0.013	CbGbCtD
Miconazole—CYP2C19—Prednisone—psoriasis	0.00558	0.0128	CbGbCtD
Miconazole—CYP2E1—Dexamethasone—psoriasis	0.00556	0.0128	CbGbCtD
Miconazole—CYP2B6—Dexamethasone—psoriasis	0.00549	0.0126	CbGbCtD
Miconazole—CYP2C19—Cyclosporine—psoriasis	0.00529	0.0122	CbGbCtD
Miconazole—ABCB1—Betamethasone—psoriasis	0.00484	0.0111	CbGbCtD
Miconazole—ABCB1—Prednisolone—psoriasis	0.00477	0.011	CbGbCtD
Miconazole—ABCB1—Hydrocortisone—psoriasis	0.00452	0.0104	CbGbCtD
Miconazole—ABCB1—Prednisone—psoriasis	0.00451	0.0104	CbGbCtD
Miconazole—CYP2C9—Cyclosporine—psoriasis	0.0044	0.0101	CbGbCtD
Miconazole—ABCB1—Cyclosporine—psoriasis	0.00427	0.00982	CbGbCtD
Miconazole—CYP2D6—Cyclosporine—psoriasis	0.00402	0.00925	CbGbCtD
Miconazole—CYP3A4—Cholecalciferol—psoriasis	0.00389	0.00895	CbGbCtD
Miconazole—CYP2C19—Dexamethasone—psoriasis	0.00349	0.00802	CbGbCtD
Miconazole—CYP3A4—Triamcinolone—psoriasis	0.00338	0.00776	CbGbCtD
Miconazole—CYP3A4—Mycophenolate mofetil—psoriasis	0.00338	0.00776	CbGbCtD
Miconazole—CYP2C9—Dexamethasone—psoriasis	0.0029	0.00666	CbGbCtD
Miconazole—CYP3A4—Betamethasone—psoriasis	0.0029	0.00666	CbGbCtD
Miconazole—CYP3A4—Prednisolone—psoriasis	0.00286	0.00657	CbGbCtD
Miconazole—ABCB1—Dexamethasone—psoriasis	0.00281	0.00647	CbGbCtD
Miconazole—CYP3A4—Hydrocortisone—psoriasis	0.00271	0.00623	CbGbCtD
Miconazole—CYP3A4—Prednisone—psoriasis	0.0027	0.00621	CbGbCtD
Miconazole—CYP2D6—Dexamethasone—psoriasis	0.00265	0.00609	CbGbCtD
Miconazole—CYP3A4—Cyclosporine—psoriasis	0.00256	0.00588	CbGbCtD
Miconazole—ABCB1—Methotrexate—psoriasis	0.00226	0.0052	CbGbCtD
Miconazole—CYP3A4—Dexamethasone—psoriasis	0.00169	0.00387	CbGbCtD
Miconazole—Nausea—Acitretin—psoriasis	0.000132	0.00112	CcSEcCtD
Miconazole—Nausea—Fluocinolone Acetonide—psoriasis	0.000131	0.00111	CcSEcCtD
Miconazole—Ill-defined disorder—Mycophenolate mofetil—psoriasis	0.000131	0.00111	CcSEcCtD
Miconazole—Malaise—Cyclosporine—psoriasis	0.00013	0.00111	CcSEcCtD
Miconazole—Anaemia—Mycophenolate mofetil—psoriasis	0.00013	0.00111	CcSEcCtD
Miconazole—Angioedema—Mycophenolate mofetil—psoriasis	0.000129	0.00109	CcSEcCtD
Miconazole—Hypersensitivity—Hydroxyurea—psoriasis	0.000128	0.00109	CcSEcCtD
Miconazole—Neutropenia—Prednisone—psoriasis	0.000128	0.00109	CcSEcCtD
Miconazole—Malaise—Mycophenolate mofetil—psoriasis	0.000127	0.00108	CcSEcCtD
Miconazole—Decreased appetite—Mycophenolic acid—psoriasis	0.000127	0.00107	CcSEcCtD
Miconazole—Cough—Cyclosporine—psoriasis	0.000126	0.00107	CcSEcCtD
Miconazole—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000126	0.00107	CcSEcCtD
Miconazole—Fatigue—Mycophenolic acid—psoriasis	0.000126	0.00107	CcSEcCtD
Miconazole—Asthenia—Hydroxyurea—psoriasis	0.000125	0.00106	CcSEcCtD
Miconazole—Pain—Mycophenolic acid—psoriasis	0.000125	0.00106	CcSEcCtD
Miconazole—Cough—Mycophenolate mofetil—psoriasis	0.000123	0.00104	CcSEcCtD
Miconazole—Ill-defined disorder—Prednisolone—psoriasis	0.000122	0.00103	CcSEcCtD
Miconazole—Discomfort—Cyclosporine—psoriasis	0.000121	0.00103	CcSEcCtD
Miconazole—Dry mouth—Cyclosporine—psoriasis	0.00012	0.00102	CcSEcCtD
Miconazole—Angioedema—Prednisolone—psoriasis	0.00012	0.00102	CcSEcCtD
Miconazole—Feeling abnormal—Mycophenolic acid—psoriasis	0.00012	0.00102	CcSEcCtD
Miconazole—Toxic epidermal necrolysis—Methotrexate—psoriasis	0.000119	0.00101	CcSEcCtD
Miconazole—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000119	0.00101	CcSEcCtD
Miconazole—Ill-defined disorder—Hydrocortisone—psoriasis	0.000119	0.00101	CcSEcCtD
Miconazole—Diarrhoea—Hydroxyurea—psoriasis	0.000119	0.00101	CcSEcCtD
Miconazole—Malaise—Prednisolone—psoriasis	0.000118	0.00101	CcSEcCtD
Miconazole—Discomfort—Mycophenolate mofetil—psoriasis	0.000118	0.00101	CcSEcCtD
Miconazole—Dysgeusia—Triamcinolone—psoriasis	0.000118	0.001	CcSEcCtD
Miconazole—Anaphylactic shock—Cyclosporine—psoriasis	0.000118	0.001	CcSEcCtD
Miconazole—Dry mouth—Mycophenolate mofetil—psoriasis	0.000117	0.000996	CcSEcCtD
Miconazole—Angioedema—Hydrocortisone—psoriasis	0.000117	0.000995	CcSEcCtD
Miconazole—Infection—Cyclosporine—psoriasis	0.000117	0.000994	CcSEcCtD
Miconazole—Malaise—Hydrocortisone—psoriasis	0.000116	0.000982	CcSEcCtD
Miconazole—Nervous system disorder—Cyclosporine—psoriasis	0.000116	0.000981	CcSEcCtD
Miconazole—Abdominal pain—Mycophenolic acid—psoriasis	0.000115	0.000977	CcSEcCtD
Miconazole—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000115	0.000976	CcSEcCtD
Miconazole—Infection—Mycophenolate mofetil—psoriasis	0.000114	0.000969	CcSEcCtD
Miconazole—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000113	0.000957	CcSEcCtD
Miconazole—Anorexia—Cyclosporine—psoriasis	0.000112	0.000954	CcSEcCtD
Miconazole—Ill-defined disorder—Triamcinolone—psoriasis	0.000112	0.000952	CcSEcCtD
Miconazole—Vomiting—Hydroxyurea—psoriasis	0.000111	0.000939	CcSEcCtD
Miconazole—Discomfort—Prednisolone—psoriasis	0.00011	0.000938	CcSEcCtD
Miconazole—Angioedema—Triamcinolone—psoriasis	0.00011	0.000937	CcSEcCtD
Miconazole—Rash—Hydroxyurea—psoriasis	0.00011	0.000931	CcSEcCtD
Miconazole—Anorexia—Mycophenolate mofetil—psoriasis	0.00011	0.00093	CcSEcCtD
Miconazole—Dermatitis—Hydroxyurea—psoriasis	0.00011	0.00093	CcSEcCtD
Miconazole—Malaise—Triamcinolone—psoriasis	0.000109	0.000925	CcSEcCtD
Miconazole—Headache—Hydroxyurea—psoriasis	0.000109	0.000925	CcSEcCtD
Miconazole—Discomfort—Hydrocortisone—psoriasis	0.000108	0.000916	CcSEcCtD
Miconazole—Anaphylactic shock—Prednisolone—psoriasis	0.000107	0.00091	CcSEcCtD
Miconazole—Neutropenia—Methotrexate—psoriasis	0.000107	0.000909	CcSEcCtD
Miconazole—Upper respiratory tract infection—Methotrexate—psoriasis	0.000106	0.000903	CcSEcCtD
Miconazole—Cough—Triamcinolone—psoriasis	0.000105	0.000895	CcSEcCtD
Miconazole—Anaphylactic shock—Hydrocortisone—psoriasis	0.000105	0.000889	CcSEcCtD
Miconazole—Asthenia—Mycophenolic acid—psoriasis	0.000104	0.000887	CcSEcCtD
Miconazole—Infection—Hydrocortisone—psoriasis	0.000104	0.000883	CcSEcCtD
Miconazole—Nausea—Hydroxyurea—psoriasis	0.000103	0.000877	CcSEcCtD
Miconazole—Pruritus—Mycophenolic acid—psoriasis	0.000103	0.000875	CcSEcCtD
Miconazole—Nervous system disorder—Hydrocortisone—psoriasis	0.000103	0.000872	CcSEcCtD
Miconazole—Decreased appetite—Cyclosporine—psoriasis	0.000102	0.00087	CcSEcCtD
Miconazole—Infestation NOS—Methotrexate—psoriasis	0.000102	0.000867	CcSEcCtD
Miconazole—Infestation—Methotrexate—psoriasis	0.000102	0.000867	CcSEcCtD
Miconazole—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000102	0.000864	CcSEcCtD
Miconazole—Ill-defined disorder—Dexamethasone—psoriasis	0.000102	0.000863	CcSEcCtD
Miconazole—Ill-defined disorder—Betamethasone—psoriasis	0.000102	0.000863	CcSEcCtD
Miconazole—Discomfort—Triamcinolone—psoriasis	0.000102	0.000863	CcSEcCtD
Miconazole—Fatigue—Cyclosporine—psoriasis	0.000102	0.000862	CcSEcCtD
Miconazole—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.000101	0.000859	CcSEcCtD
Miconazole—Pain—Cyclosporine—psoriasis	0.000101	0.000855	CcSEcCtD
Miconazole—Dry mouth—Triamcinolone—psoriasis	0.000101	0.000854	CcSEcCtD
Miconazole—Angioedema—Betamethasone—psoriasis	0.0001	0.00085	CcSEcCtD
Miconazole—Angioedema—Dexamethasone—psoriasis	0.0001	0.00085	CcSEcCtD
Miconazole—Decreased appetite—Mycophenolate mofetil—psoriasis	9.99e-05	0.000848	CcSEcCtD
Miconazole—Anorexia—Hydrocortisone—psoriasis	9.98e-05	0.000847	CcSEcCtD
Miconazole—Diarrhoea—Mycophenolic acid—psoriasis	9.96e-05	0.000846	CcSEcCtD
Miconazole—Stomatitis—Methotrexate—psoriasis	9.95e-05	0.000845	CcSEcCtD
Miconazole—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	9.92e-05	0.000842	CcSEcCtD
Miconazole—Immune system disorder—Prednisone—psoriasis	9.9e-05	0.000841	CcSEcCtD
Miconazole—Malaise—Betamethasone—psoriasis	9.88e-05	0.000839	CcSEcCtD
Miconazole—Malaise—Dexamethasone—psoriasis	9.88e-05	0.000839	CcSEcCtD
Miconazole—Anaphylactic shock—Triamcinolone—psoriasis	9.86e-05	0.000837	CcSEcCtD
Miconazole—Pain—Mycophenolate mofetil—psoriasis	9.83e-05	0.000834	CcSEcCtD
Miconazole—Infection—Triamcinolone—psoriasis	9.79e-05	0.000832	CcSEcCtD
Miconazole—Feeling abnormal—Cyclosporine—psoriasis	9.71e-05	0.000824	CcSEcCtD
Miconazole—Hepatobiliary disease—Methotrexate—psoriasis	9.65e-05	0.00082	CcSEcCtD
Miconazole—Gastrointestinal pain—Cyclosporine—psoriasis	9.63e-05	0.000818	CcSEcCtD
Miconazole—Feeling abnormal—Mycophenolate mofetil—psoriasis	9.47e-05	0.000804	CcSEcCtD
Miconazole—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	9.4e-05	0.000798	CcSEcCtD
Miconazole—Urticaria—Cyclosporine—psoriasis	9.36e-05	0.000795	CcSEcCtD
Miconazole—Abdominal pain—Cyclosporine—psoriasis	9.31e-05	0.000791	CcSEcCtD
Miconazole—Vomiting—Mycophenolic acid—psoriasis	9.26e-05	0.000786	CcSEcCtD
Miconazole—Discomfort—Dexamethasone—psoriasis	9.22e-05	0.000783	CcSEcCtD
Miconazole—Discomfort—Betamethasone—psoriasis	9.22e-05	0.000783	CcSEcCtD
Miconazole—Rash—Mycophenolic acid—psoriasis	9.18e-05	0.00078	CcSEcCtD
Miconazole—Dermatitis—Mycophenolic acid—psoriasis	9.17e-05	0.000779	CcSEcCtD
Miconazole—Pain—Prednisolone—psoriasis	9.17e-05	0.000778	CcSEcCtD
Miconazole—Hepatitis—Methotrexate—psoriasis	9.16e-05	0.000778	CcSEcCtD
Miconazole—Urticaria—Mycophenolate mofetil—psoriasis	9.13e-05	0.000775	CcSEcCtD
Miconazole—Headache—Mycophenolic acid—psoriasis	9.12e-05	0.000775	CcSEcCtD
Miconazole—Decreased appetite—Hydrocortisone—psoriasis	9.1e-05	0.000773	CcSEcCtD
Miconazole—Abdominal pain—Mycophenolate mofetil—psoriasis	9.08e-05	0.000771	CcSEcCtD
Miconazole—Gastrointestinal disorder—Hydrocortisone—psoriasis	9.04e-05	0.000768	CcSEcCtD
Miconazole—Fatigue—Hydrocortisone—psoriasis	9.03e-05	0.000766	CcSEcCtD
Miconazole—Pain—Hydrocortisone—psoriasis	8.95e-05	0.00076	CcSEcCtD
Miconazole—Anaphylactic shock—Betamethasone—psoriasis	8.94e-05	0.00076	CcSEcCtD
Miconazole—Anaphylactic shock—Dexamethasone—psoriasis	8.94e-05	0.00076	CcSEcCtD
Miconazole—Infection—Betamethasone—psoriasis	8.89e-05	0.000755	CcSEcCtD
Miconazole—Infection—Dexamethasone—psoriasis	8.89e-05	0.000755	CcSEcCtD
Miconazole—Ill-defined disorder—Prednisone—psoriasis	8.86e-05	0.000752	CcSEcCtD
Miconazole—Feeling abnormal—Prednisolone—psoriasis	8.83e-05	0.00075	CcSEcCtD
Miconazole—Anaemia—Prednisone—psoriasis	8.82e-05	0.000749	CcSEcCtD
Miconazole—Nervous system disorder—Betamethasone—psoriasis	8.77e-05	0.000745	CcSEcCtD
Miconazole—Nervous system disorder—Dexamethasone—psoriasis	8.77e-05	0.000745	CcSEcCtD
Miconazole—Angioedema—Prednisone—psoriasis	8.72e-05	0.000741	CcSEcCtD
Miconazole—Hypersensitivity—Cyclosporine—psoriasis	8.68e-05	0.000737	CcSEcCtD
Miconazole—Erythema multiforme—Methotrexate—psoriasis	8.66e-05	0.000736	CcSEcCtD
Miconazole—Nausea—Mycophenolic acid—psoriasis	8.65e-05	0.000734	CcSEcCtD
Miconazole—Feeling abnormal—Hydrocortisone—psoriasis	8.63e-05	0.000733	CcSEcCtD
Miconazole—Malaise—Prednisone—psoriasis	8.61e-05	0.000731	CcSEcCtD
Miconazole—Gastrointestinal pain—Hydrocortisone—psoriasis	8.56e-05	0.000727	CcSEcCtD
Miconazole—Anorexia—Dexamethasone—psoriasis	8.53e-05	0.000724	CcSEcCtD
Miconazole—Anorexia—Betamethasone—psoriasis	8.53e-05	0.000724	CcSEcCtD
Miconazole—Urticaria—Prednisolone—psoriasis	8.52e-05	0.000723	CcSEcCtD
Miconazole—Fatigue—Triamcinolone—psoriasis	8.5e-05	0.000722	CcSEcCtD
Miconazole—Hypersensitivity—Mycophenolate mofetil—psoriasis	8.47e-05	0.000719	CcSEcCtD
Miconazole—Asthenia—Cyclosporine—psoriasis	8.45e-05	0.000718	CcSEcCtD
Miconazole—Pain—Triamcinolone—psoriasis	8.43e-05	0.000716	CcSEcCtD
Miconazole—Pruritus—Cyclosporine—psoriasis	8.33e-05	0.000708	CcSEcCtD
Miconazole—Urticaria—Hydrocortisone—psoriasis	8.32e-05	0.000706	CcSEcCtD
Miconazole—Immune system disorder—Methotrexate—psoriasis	8.28e-05	0.000703	CcSEcCtD
Miconazole—Abdominal pain—Hydrocortisone—psoriasis	8.28e-05	0.000703	CcSEcCtD
Miconazole—Mediastinal disorder—Methotrexate—psoriasis	8.26e-05	0.000701	CcSEcCtD
Miconazole—Asthenia—Mycophenolate mofetil—psoriasis	8.24e-05	0.0007	CcSEcCtD
Miconazole—Chills—Methotrexate—psoriasis	8.22e-05	0.000698	CcSEcCtD
Miconazole—Pruritus—Mycophenolate mofetil—psoriasis	8.13e-05	0.00069	CcSEcCtD
Miconazole—Feeling abnormal—Triamcinolone—psoriasis	8.12e-05	0.00069	CcSEcCtD
Miconazole—Diarrhoea—Cyclosporine—psoriasis	8.06e-05	0.000684	CcSEcCtD
Miconazole—Discomfort—Prednisone—psoriasis	8.03e-05	0.000682	CcSEcCtD
Miconazole—Hypersensitivity—Prednisolone—psoriasis	7.9e-05	0.000671	CcSEcCtD
Miconazole—Diarrhoea—Mycophenolate mofetil—psoriasis	7.86e-05	0.000668	CcSEcCtD
Miconazole—Urticaria—Triamcinolone—psoriasis	7.83e-05	0.000665	CcSEcCtD
Miconazole—Dysgeusia—Methotrexate—psoriasis	7.81e-05	0.000663	CcSEcCtD
Miconazole—Anaphylactic shock—Prednisone—psoriasis	7.79e-05	0.000661	CcSEcCtD
Miconazole—Decreased appetite—Dexamethasone—psoriasis	7.78e-05	0.00066	CcSEcCtD
Miconazole—Decreased appetite—Betamethasone—psoriasis	7.78e-05	0.00066	CcSEcCtD
Miconazole—Infection—Prednisone—psoriasis	7.74e-05	0.000657	CcSEcCtD
Miconazole—Gastrointestinal disorder—Betamethasone—psoriasis	7.72e-05	0.000656	CcSEcCtD
Miconazole—Gastrointestinal disorder—Dexamethasone—psoriasis	7.72e-05	0.000656	CcSEcCtD
Miconazole—Hypersensitivity—Hydrocortisone—psoriasis	7.71e-05	0.000655	CcSEcCtD
Miconazole—Fatigue—Dexamethasone—psoriasis	7.71e-05	0.000655	CcSEcCtD
Miconazole—Fatigue—Betamethasone—psoriasis	7.71e-05	0.000655	CcSEcCtD
Miconazole—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	7.65e-05	0.00103	CbGpPWpGaD
Miconazole—Pain—Dexamethasone—psoriasis	7.65e-05	0.00065	CcSEcCtD
Miconazole—Pain—Betamethasone—psoriasis	7.65e-05	0.00065	CcSEcCtD
Miconazole—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—psoriasis	7.64e-05	0.00103	CbGpPWpGaD
Miconazole—Nervous system disorder—Prednisone—psoriasis	7.64e-05	0.000649	CcSEcCtD
Miconazole—NOS2—ATF-2 transcription factor network—IL6—psoriasis	7.63e-05	0.00103	CbGpPWpGaD
Miconazole—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	7.61e-05	0.00103	CbGpPWpGaD
Miconazole—KCNH2—SIDS Susceptibility Pathways—IL10—psoriasis	7.53e-05	0.00102	CbGpPWpGaD
Miconazole—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—psoriasis	7.53e-05	0.00102	CbGpPWpGaD
Miconazole—NOS3—VEGFA-VEGFR2 Pathway—TYK2—psoriasis	7.52e-05	0.00102	CbGpPWpGaD
Miconazole—Asthenia—Hydrocortisone—psoriasis	7.51e-05	0.000638	CcSEcCtD
Miconazole—Vomiting—Cyclosporine—psoriasis	7.49e-05	0.000636	CcSEcCtD
Miconazole—KCNMA1—Circadian rythm related genes—PPARG—psoriasis	7.48e-05	0.00101	CbGpPWpGaD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	7.45e-05	0.00101	CbGpPWpGaD
Miconazole—Rash—Cyclosporine—psoriasis	7.43e-05	0.000631	CcSEcCtD
Miconazole—Anorexia—Prednisone—psoriasis	7.43e-05	0.000631	CcSEcCtD
Miconazole—Dermatitis—Cyclosporine—psoriasis	7.42e-05	0.00063	CcSEcCtD
Miconazole—Pruritus—Hydrocortisone—psoriasis	7.41e-05	0.000629	CcSEcCtD
Miconazole—Ill-defined disorder—Methotrexate—psoriasis	7.4e-05	0.000628	CcSEcCtD
Miconazole—NOS3—Corticotropin-releasing hormone—CXCL8—psoriasis	7.39e-05	0.000997	CbGpPWpGaD
Miconazole—KCNH7—Circadian rythm related genes—JUN—psoriasis	7.38e-05	0.000997	CbGpPWpGaD
Miconazole—Headache—Cyclosporine—psoriasis	7.38e-05	0.000627	CcSEcCtD
Miconazole—Anaemia—Methotrexate—psoriasis	7.37e-05	0.000626	CcSEcCtD
Miconazole—Feeling abnormal—Betamethasone—psoriasis	7.37e-05	0.000626	CcSEcCtD
Miconazole—Feeling abnormal—Dexamethasone—psoriasis	7.37e-05	0.000626	CcSEcCtD
Miconazole—Gastrointestinal pain—Dexamethasone—psoriasis	7.31e-05	0.000621	CcSEcCtD
Miconazole—Gastrointestinal pain—Betamethasone—psoriasis	7.31e-05	0.000621	CcSEcCtD
Miconazole—Vomiting—Mycophenolate mofetil—psoriasis	7.31e-05	0.00062	CcSEcCtD
Miconazole—Hypersensitivity—Triamcinolone—psoriasis	7.26e-05	0.000617	CcSEcCtD
Miconazole—Rash—Mycophenolate mofetil—psoriasis	7.25e-05	0.000615	CcSEcCtD
Miconazole—Dermatitis—Mycophenolate mofetil—psoriasis	7.24e-05	0.000615	CcSEcCtD
Miconazole—Headache—Mycophenolate mofetil—psoriasis	7.2e-05	0.000611	CcSEcCtD
Miconazole—Malaise—Methotrexate—psoriasis	7.19e-05	0.000611	CcSEcCtD
Miconazole—Diarrhoea—Hydrocortisone—psoriasis	7.16e-05	0.000608	CcSEcCtD
Miconazole—CYP11B1—Corticotropin-releasing hormone—NFKB1—psoriasis	7.14e-05	0.000964	CbGpPWpGaD
Miconazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.13e-05	0.000962	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—HLA-C—psoriasis	7.12e-05	0.000961	CbGpPWpGaD
Miconazole—Urticaria—Dexamethasone—psoriasis	7.11e-05	0.000603	CcSEcCtD
Miconazole—Urticaria—Betamethasone—psoriasis	7.11e-05	0.000603	CcSEcCtD
Miconazole—NOS3—Signaling by VEGF—TYK2—psoriasis	7.1e-05	0.000958	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—IL13—psoriasis	7.07e-05	0.000955	CbGpPWpGaD
Miconazole—Asthenia—Triamcinolone—psoriasis	7.07e-05	0.000601	CcSEcCtD
Miconazole—Abdominal pain—Dexamethasone—psoriasis	7.07e-05	0.0006	CcSEcCtD
Miconazole—Abdominal pain—Betamethasone—psoriasis	7.07e-05	0.0006	CcSEcCtD
Miconazole—NOS3—Leptin signaling pathway—STAT3—psoriasis	7e-05	0.000945	CbGpPWpGaD
Miconazole—Nausea—Cyclosporine—psoriasis	7e-05	0.000594	CcSEcCtD
Miconazole—Pruritus—Triamcinolone—psoriasis	6.97e-05	0.000592	CcSEcCtD
Miconazole—Cough—Methotrexate—psoriasis	6.96e-05	0.000591	CcSEcCtD
Miconazole—CYP51A1—Metabolism—NDUFA5—psoriasis	6.9e-05	0.000932	CbGpPWpGaD
Miconazole—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—psoriasis	6.87e-05	0.000928	CbGpPWpGaD
Miconazole—Nausea—Mycophenolate mofetil—psoriasis	6.83e-05	0.00058	CcSEcCtD
Miconazole—Decreased appetite—Prednisone—psoriasis	6.77e-05	0.000575	CcSEcCtD
Miconazole—Rash—Prednisolone—psoriasis	6.76e-05	0.000574	CcSEcCtD
Miconazole—Dermatitis—Prednisolone—psoriasis	6.75e-05	0.000573	CcSEcCtD
Miconazole—Fatigue—Prednisone—psoriasis	6.72e-05	0.00057	CcSEcCtD
Miconazole—Headache—Prednisolone—psoriasis	6.72e-05	0.00057	CcSEcCtD
Miconazole—Discomfort—Methotrexate—psoriasis	6.71e-05	0.00057	CcSEcCtD
Miconazole—CYP1A2—Biological oxidations—CYP2S1—psoriasis	6.68e-05	0.000902	CbGpPWpGaD
Miconazole—NOS2—Circadian rythm related genes—PPARG—psoriasis	6.68e-05	0.000901	CbGpPWpGaD
Miconazole—Vomiting—Hydrocortisone—psoriasis	6.66e-05	0.000565	CcSEcCtD
Miconazole—NOS3—Corticotropin-releasing hormone—NFKB1—psoriasis	6.61e-05	0.000893	CbGpPWpGaD
Miconazole—Rash—Hydrocortisone—psoriasis	6.6e-05	0.000561	CcSEcCtD
Miconazole—Dermatitis—Hydrocortisone—psoriasis	6.59e-05	0.00056	CcSEcCtD
Miconazole—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	6.59e-05	0.00089	CbGpPWpGaD
Miconazole—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	6.58e-05	0.000888	CbGpPWpGaD
Miconazole—Headache—Hydrocortisone—psoriasis	6.56e-05	0.000557	CcSEcCtD
Miconazole—ABCB1—Allograft Rejection—IL17A—psoriasis	6.51e-05	0.000879	CbGpPWpGaD
Miconazole—Anaphylactic shock—Methotrexate—psoriasis	6.51e-05	0.000553	CcSEcCtD
Miconazole—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	6.48e-05	0.000875	CbGpPWpGaD
Miconazole—Infection—Methotrexate—psoriasis	6.47e-05	0.000549	CcSEcCtD
Miconazole—NOS3—Hemostasis—ITGAL—psoriasis	6.46e-05	0.000872	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.43e-05	0.000869	CbGpPWpGaD
Miconazole—Feeling abnormal—Prednisone—psoriasis	6.42e-05	0.000545	CcSEcCtD
Miconazole—Asthenia—Betamethasone—psoriasis	6.42e-05	0.000545	CcSEcCtD
Miconazole—Asthenia—Dexamethasone—psoriasis	6.42e-05	0.000545	CcSEcCtD
Miconazole—Nervous system disorder—Methotrexate—psoriasis	6.38e-05	0.000542	CcSEcCtD
Miconazole—Gastrointestinal pain—Prednisone—psoriasis	6.37e-05	0.000541	CcSEcCtD
Miconazole—Nausea—Prednisolone—psoriasis	6.37e-05	0.000541	CcSEcCtD
Miconazole—Pruritus—Dexamethasone—psoriasis	6.33e-05	0.000537	CcSEcCtD
Miconazole—Pruritus—Betamethasone—psoriasis	6.33e-05	0.000537	CcSEcCtD
Miconazole—CYP11B1—Metabolism—NDUFA5—psoriasis	6.27e-05	0.000847	CbGpPWpGaD
Miconazole—Vomiting—Triamcinolone—psoriasis	6.27e-05	0.000532	CcSEcCtD
Miconazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.23e-05	0.00084	CbGpPWpGaD
Miconazole—Nausea—Hydrocortisone—psoriasis	6.22e-05	0.000528	CcSEcCtD
Miconazole—Rash—Triamcinolone—psoriasis	6.22e-05	0.000528	CcSEcCtD
Miconazole—Dermatitis—Triamcinolone—psoriasis	6.21e-05	0.000527	CcSEcCtD
Miconazole—Anorexia—Methotrexate—psoriasis	6.21e-05	0.000527	CcSEcCtD
Miconazole—Urticaria—Prednisone—psoriasis	6.19e-05	0.000525	CcSEcCtD
Miconazole—Headache—Triamcinolone—psoriasis	6.18e-05	0.000524	CcSEcCtD
Miconazole—Abdominal pain—Prednisone—psoriasis	6.16e-05	0.000523	CcSEcCtD
Miconazole—Diarrhoea—Betamethasone—psoriasis	6.12e-05	0.00052	CcSEcCtD
Miconazole—Diarrhoea—Dexamethasone—psoriasis	6.12e-05	0.00052	CcSEcCtD
Miconazole—ABCB1—Allograft Rejection—IL12B—psoriasis	6.05e-05	0.000817	CbGpPWpGaD
Miconazole—NOS3—SHP2 signaling—IL6—psoriasis	6e-05	0.00081	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—HLA-E—psoriasis	5.91e-05	0.000798	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism—CYP2S1—psoriasis	5.87e-05	0.000792	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism—NDUFA5—psoriasis	5.87e-05	0.000792	CbGpPWpGaD
Miconazole—Nausea—Triamcinolone—psoriasis	5.86e-05	0.000497	CcSEcCtD
Miconazole—CYP11B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.85e-05	0.00079	CbGpPWpGaD
Miconazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.82e-05	0.000785	CbGpPWpGaD
Miconazole—NOS3—Metabolism—NDUFA5—psoriasis	5.81e-05	0.000784	CbGpPWpGaD
Miconazole—CYP1A2—Tryptophan metabolism—CAT—psoriasis	5.77e-05	0.000778	CbGpPWpGaD
Miconazole—Hypersensitivity—Prednisone—psoriasis	5.74e-05	0.000487	CcSEcCtD
Miconazole—Vomiting—Betamethasone—psoriasis	5.69e-05	0.000483	CcSEcCtD
Miconazole—Vomiting—Dexamethasone—psoriasis	5.69e-05	0.000483	CcSEcCtD
Miconazole—Decreased appetite—Methotrexate—psoriasis	5.66e-05	0.000481	CcSEcCtD
Miconazole—Rash—Dexamethasone—psoriasis	5.64e-05	0.000479	CcSEcCtD
Miconazole—Rash—Betamethasone—psoriasis	5.64e-05	0.000479	CcSEcCtD
Miconazole—Dermatitis—Betamethasone—psoriasis	5.63e-05	0.000478	CcSEcCtD
Miconazole—Dermatitis—Dexamethasone—psoriasis	5.63e-05	0.000478	CcSEcCtD
Miconazole—Gastrointestinal disorder—Methotrexate—psoriasis	5.62e-05	0.000477	CcSEcCtD
Miconazole—Fatigue—Methotrexate—psoriasis	5.61e-05	0.000477	CcSEcCtD
Miconazole—Headache—Dexamethasone—psoriasis	5.6e-05	0.000476	CcSEcCtD
Miconazole—Headache—Betamethasone—psoriasis	5.6e-05	0.000476	CcSEcCtD
Miconazole—Asthenia—Prednisone—psoriasis	5.59e-05	0.000475	CcSEcCtD
Miconazole—Pain—Methotrexate—psoriasis	5.57e-05	0.000473	CcSEcCtD
Miconazole—Pruritus—Prednisone—psoriasis	5.51e-05	0.000468	CcSEcCtD
Miconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.5e-05	0.000743	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.47e-05	0.000739	CbGpPWpGaD
Miconazole—NOS2—Spinal Cord Injury—TNF—psoriasis	5.43e-05	0.000733	CbGpPWpGaD
Miconazole—KCNMB3—Hemostasis—VEGFA—psoriasis	5.37e-05	0.000724	CbGpPWpGaD
Miconazole—KCNMB4—Hemostasis—VEGFA—psoriasis	5.37e-05	0.000724	CbGpPWpGaD
Miconazole—KCNMB1—Hemostasis—VEGFA—psoriasis	5.37e-05	0.000724	CbGpPWpGaD
Miconazole—KCNMB2—Hemostasis—VEGFA—psoriasis	5.37e-05	0.000724	CbGpPWpGaD
Miconazole—Feeling abnormal—Methotrexate—psoriasis	5.36e-05	0.000456	CcSEcCtD
Miconazole—CYP11B1—Metabolism—CYP2S1—psoriasis	5.33e-05	0.00072	CbGpPWpGaD
Miconazole—Diarrhoea—Prednisone—psoriasis	5.33e-05	0.000453	CcSEcCtD
Miconazole—Gastrointestinal pain—Methotrexate—psoriasis	5.32e-05	0.000452	CcSEcCtD
Miconazole—NOS3—VEGFA-VEGFR2 Pathway—VEGFA—psoriasis	5.32e-05	0.000718	CbGpPWpGaD
Miconazole—Nausea—Dexamethasone—psoriasis	5.31e-05	0.000451	CcSEcCtD
Miconazole—Nausea—Betamethasone—psoriasis	5.31e-05	0.000451	CcSEcCtD
Miconazole—KCNMA1—Circadian rythm related genes—JUN—psoriasis	5.3e-05	0.000716	CbGpPWpGaD
Miconazole—Urticaria—Methotrexate—psoriasis	5.17e-05	0.000439	CcSEcCtD
Miconazole—CYP3A4—Biological oxidations—CYP2S1—psoriasis	5.16e-05	0.000696	CbGpPWpGaD
Miconazole—Abdominal pain—Methotrexate—psoriasis	5.15e-05	0.000437	CcSEcCtD
Miconazole—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	5.09e-05	0.000687	CbGpPWpGaD
Miconazole—NOS3—Signaling by VEGF—VEGFA—psoriasis	5.02e-05	0.000678	CbGpPWpGaD
Miconazole—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	5.02e-05	0.000677	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism—CYP2S1—psoriasis	4.99e-05	0.000674	CbGpPWpGaD
Miconazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.97e-05	0.000671	CbGpPWpGaD
Miconazole—Vomiting—Prednisone—psoriasis	4.95e-05	0.000421	CcSEcCtD
Miconazole—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	4.95e-05	0.000668	CbGpPWpGaD
Miconazole—NOS3—Metabolism—CYP2S1—psoriasis	4.94e-05	0.000667	CbGpPWpGaD
Miconazole—Rash—Prednisone—psoriasis	4.91e-05	0.000417	CcSEcCtD
Miconazole—Dermatitis—Prednisone—psoriasis	4.91e-05	0.000417	CcSEcCtD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	4.89e-05	0.00066	CbGpPWpGaD
Miconazole—Headache—Prednisone—psoriasis	4.88e-05	0.000414	CcSEcCtD
Miconazole—KCNH7—Circadian rythm related genes—TP53—psoriasis	4.87e-05	0.000658	CbGpPWpGaD
Miconazole—Hypersensitivity—Methotrexate—psoriasis	4.8e-05	0.000407	CcSEcCtD
Miconazole—NOS2—Spinal Cord Injury—TP53—psoriasis	4.79e-05	0.000646	CbGpPWpGaD
Miconazole—NOS2—Circadian rythm related genes—JUN—psoriasis	4.73e-05	0.000639	CbGpPWpGaD
Miconazole—Asthenia—Methotrexate—psoriasis	4.67e-05	0.000397	CcSEcCtD
Miconazole—Nausea—Prednisone—psoriasis	4.63e-05	0.000393	CcSEcCtD
Miconazole—Pruritus—Methotrexate—psoriasis	4.61e-05	0.000391	CcSEcCtD
Miconazole—NOS3—Signaling Pathways—HCAR2—psoriasis	4.57e-05	0.000616	CbGpPWpGaD
Miconazole—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	4.55e-05	0.000614	CbGpPWpGaD
Miconazole—NOS3—Myometrial Relaxation and Contraction Pathways—JUN—psoriasis	4.53e-05	0.000611	CbGpPWpGaD
Miconazole—KCNH7—Circadian rythm related genes—IL6—psoriasis	4.46e-05	0.000602	CbGpPWpGaD
Miconazole—Diarrhoea—Methotrexate—psoriasis	4.45e-05	0.000378	CcSEcCtD
Miconazole—CYP3A4—Tryptophan metabolism—CAT—psoriasis	4.45e-05	0.000601	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—IL10—psoriasis	4.43e-05	0.000597	CbGpPWpGaD
Miconazole—NOS2—Spinal Cord Injury—IL6—psoriasis	4.38e-05	0.000591	CbGpPWpGaD
Miconazole—NOS3—EGF/EGFR Signaling Pathway—JUN—psoriasis	4.37e-05	0.00059	CbGpPWpGaD
Miconazole—NOS3—Myometrial Relaxation and Contraction Pathways—NFKB1—psoriasis	4.36e-05	0.000588	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—IL4—psoriasis	4.31e-05	0.000581	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—HLA-B—psoriasis	4.21e-05	0.000568	CbGpPWpGaD
Miconazole—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	4.2e-05	0.000568	CbGpPWpGaD
Miconazole—Vomiting—Methotrexate—psoriasis	4.14e-05	0.000351	CcSEcCtD
Miconazole—KCNH2—SIDS Susceptibility Pathways—CXCL8—psoriasis	4.12e-05	0.000556	CbGpPWpGaD
Miconazole—Rash—Methotrexate—psoriasis	4.1e-05	0.000349	CcSEcCtD
Miconazole—Dermatitis—Methotrexate—psoriasis	4.1e-05	0.000348	CcSEcCtD
Miconazole—Headache—Methotrexate—psoriasis	4.08e-05	0.000346	CcSEcCtD
Miconazole—KCNMB4—Hemostasis—TP53—psoriasis	4.05e-05	0.000547	CbGpPWpGaD
Miconazole—KCNMB3—Hemostasis—TP53—psoriasis	4.05e-05	0.000547	CbGpPWpGaD
Miconazole—KCNMB2—Hemostasis—TP53—psoriasis	4.05e-05	0.000547	CbGpPWpGaD
Miconazole—KCNMB1—Hemostasis—TP53—psoriasis	4.05e-05	0.000547	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—TAGAP—psoriasis	3.96e-05	0.000534	CbGpPWpGaD
Miconazole—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	3.92e-05	0.000529	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—HLA-A—psoriasis	3.9e-05	0.000527	CbGpPWpGaD
Miconazole—Nausea—Methotrexate—psoriasis	3.87e-05	0.000328	CcSEcCtD
Miconazole—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	3.85e-05	0.00052	CbGpPWpGaD
Miconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.84e-05	0.000518	CbGpPWpGaD
Miconazole—KCNH2—SIDS Susceptibility Pathways—JUN—psoriasis	3.83e-05	0.000517	CbGpPWpGaD
Miconazole—KCNMA1—Hemostasis—NOS2—psoriasis	3.82e-05	0.000516	CbGpPWpGaD
Miconazole—NOS3—EGF/EGFR Signaling Pathway—STAT3—psoriasis	3.78e-05	0.00051	CbGpPWpGaD
Miconazole—KCNH2—SIDS Susceptibility Pathways—NFKB1—psoriasis	3.69e-05	0.000497	CbGpPWpGaD
Miconazole—NOS3—VEGFA-VEGFR2 Pathway—IL6—psoriasis	3.68e-05	0.000497	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	3.56e-05	0.000481	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism—NDUFA5—psoriasis	3.56e-05	0.00048	CbGpPWpGaD
Miconazole—KCNMA1—Circadian rythm related genes—TP53—psoriasis	3.5e-05	0.000473	CbGpPWpGaD
Miconazole—NOS3—Signaling by VEGF—IL6—psoriasis	3.47e-05	0.000469	CbGpPWpGaD
Miconazole—KCNH2—SIDS Susceptibility Pathways—VEGFA—psoriasis	3.34e-05	0.000452	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.31e-05	0.000447	CbGpPWpGaD
Miconazole—KCNMA1—Circadian rythm related genes—IL6—psoriasis	3.2e-05	0.000433	CbGpPWpGaD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	3.2e-05	0.000432	CbGpPWpGaD
Miconazole—NOS2—Circadian rythm related genes—TP53—psoriasis	3.13e-05	0.000422	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.08e-05	0.000415	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism—CYP2S1—psoriasis	3.02e-05	0.000408	CbGpPWpGaD
Miconazole—KCNH2—SIDS Susceptibility Pathways—TNF—psoriasis	2.87e-05	0.000387	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism—CARM1—psoriasis	2.87e-05	0.000387	CbGpPWpGaD
Miconazole—NOS2—Circadian rythm related genes—IL6—psoriasis	2.86e-05	0.000386	CbGpPWpGaD
Miconazole—CYP2A6—Metabolism—NDUFA5—psoriasis	2.83e-05	0.000382	CbGpPWpGaD
Miconazole—CYP19A1—Integrated Breast Cancer Pathway—JUN—psoriasis	2.83e-05	0.000382	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.8e-05	0.000377	CbGpPWpGaD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	2.77e-05	0.000374	CbGpPWpGaD
Miconazole—NOS3—Myometrial Relaxation and Contraction Pathways—IL6—psoriasis	2.73e-05	0.000369	CbGpPWpGaD
Miconazole—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	2.72e-05	0.000368	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.68e-05	0.000362	CbGpPWpGaD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	2.66e-05	0.00036	CbGpPWpGaD
Miconazole—NOS3—Hemostasis—NOS2—psoriasis	2.65e-05	0.000358	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.61e-05	0.000353	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism—CARM1—psoriasis	2.61e-05	0.000352	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—IFNG—psoriasis	2.6e-05	0.000351	CbGpPWpGaD
Miconazole—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.6e-05	0.000351	CbGpPWpGaD
Miconazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	2.47e-05	0.000334	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism—CARM1—psoriasis	2.44e-05	0.000329	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.43e-05	0.000329	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.42e-05	0.000327	CbGpPWpGaD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.42e-05	0.000326	CbGpPWpGaD
Miconazole—NOS3—Metabolism—CARM1—psoriasis	2.41e-05	0.000326	CbGpPWpGaD
Miconazole—CYP2A6—Metabolism—CYP2S1—psoriasis	2.41e-05	0.000325	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—CCL20—psoriasis	2.37e-05	0.00032	CbGpPWpGaD
Miconazole—KCNH2—SIDS Susceptibility Pathways—IL6—psoriasis	2.31e-05	0.000312	CbGpPWpGaD
Miconazole—CYP2B6—Metabolism—NDUFA5—psoriasis	2.28e-05	0.000308	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.28e-05	0.000307	CbGpPWpGaD
Miconazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.27e-05	0.000306	CbGpPWpGaD
Miconazole—CYP2E1—Metabolism—NDUFA5—psoriasis	2.24e-05	0.000302	CbGpPWpGaD
Miconazole—KCNMA1—Hemostasis—VEGFA—psoriasis	2.21e-05	0.000299	CbGpPWpGaD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.07e-05	0.00028	CbGpPWpGaD
Miconazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.07e-05	0.00028	CbGpPWpGaD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.99e-05	0.000269	CbGpPWpGaD
Miconazole—NOS2—Hemostasis—VEGFA—psoriasis	1.98e-05	0.000267	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.97e-05	0.000265	CbGpPWpGaD
Miconazole—CYP2B6—Metabolism—CYP2S1—psoriasis	1.94e-05	0.000262	CbGpPWpGaD
Miconazole—CYP2E1—Metabolism—CYP2S1—psoriasis	1.9e-05	0.000257	CbGpPWpGaD
Miconazole—NOS2—Disease—HLA-A—psoriasis	1.9e-05	0.000256	CbGpPWpGaD
Miconazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—psoriasis	1.87e-05	0.000252	CbGpPWpGaD
Miconazole—NOS2—Disease—APOE—psoriasis	1.77e-05	0.000239	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism—CAT—psoriasis	1.76e-05	0.000238	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism—NDUFA5—psoriasis	1.73e-05	0.000233	CbGpPWpGaD
Miconazole—ABCB1—Allograft Rejection—TNF—psoriasis	1.68e-05	0.000227	CbGpPWpGaD
Miconazole—ABCB1—Metabolism—NDUFA5—psoriasis	1.68e-05	0.000227	CbGpPWpGaD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.67e-05	0.000226	CbGpPWpGaD
Miconazole—KCNMA1—Hemostasis—TP53—psoriasis	1.67e-05	0.000226	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.61e-05	0.000217	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism—CAT—psoriasis	1.6e-05	0.000216	CbGpPWpGaD
Miconazole—CYP2D6—Metabolism—NDUFA5—psoriasis	1.59e-05	0.000214	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.58e-05	0.000214	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism—NDUFA5—psoriasis	1.57e-05	0.000212	CbGpPWpGaD
Miconazole—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.56e-05	0.000211	CbGpPWpGaD
Miconazole—NOS3—Hemostasis—VEGFA—psoriasis	1.53e-05	0.000207	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism—CAT—psoriasis	1.5e-05	0.000202	CbGpPWpGaD
Miconazole—NOS2—Hemostasis—TP53—psoriasis	1.49e-05	0.000202	CbGpPWpGaD
Miconazole—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.49e-05	0.000202	CbGpPWpGaD
Miconazole—NOS3—Metabolism—CAT—psoriasis	1.48e-05	0.0002	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism—CARM1—psoriasis	1.48e-05	0.000199	CbGpPWpGaD
Miconazole—NOS3—Disease—HLA-A—psoriasis	1.47e-05	0.000199	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism—CYP2S1—psoriasis	1.47e-05	0.000198	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.47e-05	0.000198	CbGpPWpGaD
Miconazole—ABCB1—Metabolism—CYP2S1—psoriasis	1.43e-05	0.000193	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.38e-05	0.000186	CbGpPWpGaD
Miconazole—NOS3—Disease—APOE—psoriasis	1.38e-05	0.000186	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism—APOE—psoriasis	1.37e-05	0.000185	CbGpPWpGaD
Miconazole—NOS2—Disease—TYK2—psoriasis	1.35e-05	0.000183	CbGpPWpGaD
Miconazole—CYP2D6—Metabolism—CYP2S1—psoriasis	1.35e-05	0.000182	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism—NDUFA5—psoriasis	1.34e-05	0.000181	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism—CYP2S1—psoriasis	1.34e-05	0.000181	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—SOCS1—psoriasis	1.31e-05	0.000176	CbGpPWpGaD
Miconazole—NOS3—Disease—NOS2—psoriasis	1.28e-05	0.000173	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.25e-05	0.000169	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism—APOE—psoriasis	1.24e-05	0.000168	CbGpPWpGaD
Miconazole—NOS2—Disease—CD4—psoriasis	1.22e-05	0.000165	CbGpPWpGaD
Miconazole—CYP51A1—Metabolism—PPARG—psoriasis	1.19e-05	0.000161	CbGpPWpGaD
Miconazole—CYP2A6—Metabolism—CARM1—psoriasis	1.18e-05	0.000159	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism—APOE—psoriasis	1.16e-05	0.000157	CbGpPWpGaD
Miconazole—NOS3—Hemostasis—TP53—psoriasis	1.16e-05	0.000157	CbGpPWpGaD
Miconazole—NOS3—Metabolism—APOE—psoriasis	1.15e-05	0.000156	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism—CYP2S1—psoriasis	1.14e-05	0.000154	CbGpPWpGaD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.11e-05	0.00015	CbGpPWpGaD
Miconazole—CYP11B1—Metabolism—PPARG—psoriasis	1.08e-05	0.000146	CbGpPWpGaD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.07e-05	0.000144	CbGpPWpGaD
Miconazole—NOS3—Disease—TYK2—psoriasis	1.05e-05	0.000142	CbGpPWpGaD
Miconazole—CYP3A4—Metabolism—NDUFA5—psoriasis	1.04e-05	0.00014	CbGpPWpGaD
Miconazole—CYP17A1—Metabolism—PPARG—psoriasis	1.01e-05	0.000137	CbGpPWpGaD
Miconazole—NOS3—Metabolism—PPARG—psoriasis	1e-05	0.000136	CbGpPWpGaD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	9.7e-06	0.000131	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—APOE—psoriasis	9.64e-06	0.00013	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—LEP—psoriasis	9.64e-06	0.00013	CbGpPWpGaD
Miconazole—NOS3—Disease—CD4—psoriasis	9.5e-06	0.000128	CbGpPWpGaD
Miconazole—CYP2B6—Metabolism—CARM1—psoriasis	9.48e-06	0.000128	CbGpPWpGaD
Miconazole—NOS2—Disease—STAT3—psoriasis	9.47e-06	0.000128	CbGpPWpGaD
Miconazole—CYP2E1—Metabolism—CARM1—psoriasis	9.29e-06	0.000125	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism—CAT—psoriasis	9.08e-06	0.000123	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—NFKBIA—psoriasis	8.98e-06	0.000121	CbGpPWpGaD
Miconazole—CYP3A4—Metabolism—CYP2S1—psoriasis	8.82e-06	0.000119	CbGpPWpGaD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	8.31e-06	0.000112	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.69e-06	0.000104	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—TYK2—psoriasis	7.36e-06	9.93e-05	CbGpPWpGaD
Miconazole—NOS3—Disease—STAT3—psoriasis	7.36e-06	9.93e-05	CbGpPWpGaD
Miconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	7.33e-06	9.89e-05	CbGpPWpGaD
Miconazole—CYP2A6—Metabolism—CAT—psoriasis	7.23e-06	9.76e-05	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism—CARM1—psoriasis	7.16e-06	9.67e-05	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism—APOE—psoriasis	7.06e-06	9.52e-05	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.01e-06	9.46e-05	CbGpPWpGaD
Miconazole—ABCB1—Metabolism—CARM1—psoriasis	6.99e-06	9.44e-05	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.7e-06	9.04e-05	CbGpPWpGaD
Miconazole—NOS2—Disease—IL6—psoriasis	6.62e-06	8.93e-05	CbGpPWpGaD
Miconazole—CYP2D6—Metabolism—CARM1—psoriasis	6.59e-06	8.89e-05	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism—CARM1—psoriasis	6.53e-06	8.82e-05	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—CXCL8—psoriasis	6.41e-06	8.65e-05	CbGpPWpGaD
Miconazole—CYP19A1—Metabolism—PPARG—psoriasis	6.15e-06	8.3e-05	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.11e-06	8.24e-05	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.99e-06	8.09e-05	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—JUN—psoriasis	5.95e-06	8.04e-05	CbGpPWpGaD
Miconazole—CYP2B6—Metabolism—CAT—psoriasis	5.83e-06	7.87e-05	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—NFKB1—psoriasis	5.73e-06	7.74e-05	CbGpPWpGaD
Miconazole—CYP2E1—Metabolism—CAT—psoriasis	5.71e-06	7.71e-05	CbGpPWpGaD
Miconazole—CYP2A6—Metabolism—APOE—psoriasis	5.62e-06	7.58e-05	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism—CARM1—psoriasis	5.58e-06	7.54e-05	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.22e-06	7.04e-05	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—VEGFA—psoriasis	5.2e-06	7.02e-05	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—STAT3—psoriasis	5.15e-06	6.95e-05	CbGpPWpGaD
Miconazole—NOS3—Disease—IL6—psoriasis	5.14e-06	6.94e-05	CbGpPWpGaD
Miconazole—CYP2A6—Metabolism—PPARG—psoriasis	4.89e-06	6.6e-05	CbGpPWpGaD
Miconazole—CYP2B6—Metabolism—APOE—psoriasis	4.53e-06	6.12e-05	CbGpPWpGaD
Miconazole—CYP2E1—Metabolism—APOE—psoriasis	4.44e-06	5.99e-05	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism—CAT—psoriasis	4.41e-06	5.95e-05	CbGpPWpGaD
Miconazole—CYP3A4—Metabolism—CARM1—psoriasis	4.31e-06	5.82e-05	CbGpPWpGaD
Miconazole—ABCB1—Metabolism—CAT—psoriasis	4.3e-06	5.81e-05	CbGpPWpGaD
Miconazole—CYP2D6—Metabolism—CAT—psoriasis	4.05e-06	5.47e-05	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism—CAT—psoriasis	4.02e-06	5.42e-05	CbGpPWpGaD
Miconazole—CYP2B6—Metabolism—PPARG—psoriasis	3.95e-06	5.33e-05	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—TP53—psoriasis	3.93e-06	5.31e-05	CbGpPWpGaD
Miconazole—CYP2E1—Metabolism—PPARG—psoriasis	3.87e-06	5.22e-05	CbGpPWpGaD
Miconazole—NOS3—Signaling Pathways—IL6—psoriasis	3.6e-06	4.86e-05	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism—CAT—psoriasis	3.43e-06	4.63e-05	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism—APOE—psoriasis	3.42e-06	4.62e-05	CbGpPWpGaD
Miconazole—ABCB1—Metabolism—APOE—psoriasis	3.34e-06	4.51e-05	CbGpPWpGaD
Miconazole—CYP2D6—Metabolism—APOE—psoriasis	3.15e-06	4.25e-05	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism—APOE—psoriasis	3.12e-06	4.21e-05	CbGpPWpGaD
Miconazole—CYP2C19—Metabolism—PPARG—psoriasis	2.98e-06	4.03e-05	CbGpPWpGaD
Miconazole—ABCB1—Metabolism—PPARG—psoriasis	2.91e-06	3.93e-05	CbGpPWpGaD
Miconazole—CYP2D6—Metabolism—PPARG—psoriasis	2.74e-06	3.7e-05	CbGpPWpGaD
Miconazole—CYP2C9—Metabolism—PPARG—psoriasis	2.72e-06	3.67e-05	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism—APOE—psoriasis	2.67e-06	3.6e-05	CbGpPWpGaD
Miconazole—CYP3A4—Metabolism—CAT—psoriasis	2.65e-06	3.58e-05	CbGpPWpGaD
Miconazole—CYP1A2—Metabolism—PPARG—psoriasis	2.32e-06	3.14e-05	CbGpPWpGaD
Miconazole—CYP3A4—Metabolism—APOE—psoriasis	2.06e-06	2.78e-05	CbGpPWpGaD
Miconazole—CYP3A4—Metabolism—PPARG—psoriasis	1.79e-06	2.42e-05	CbGpPWpGaD
